PGNX
Invesco’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-459,930
| Closed | -$1.75M | – | 3685 |
|
2020
Q1 | $1.75M | Sell |
459,930
-20,251
| -4% | -$77K | ﹤0.01% | 2463 |
|
2019
Q4 | $2.44M | Buy |
480,181
+34,608
| +8% | +$176K | ﹤0.01% | 2542 |
|
2019
Q3 | $2.25M | Sell |
445,573
-73,456
| -14% | -$371K | ﹤0.01% | 2561 |
|
2019
Q2 | $3.2M | Sell |
519,029
-211,725
| -29% | -$1.31M | ﹤0.01% | 2434 |
|
2019
Q1 | $3.39M | Sell |
730,754
-125,995
| -15% | -$585K | ﹤0.01% | 2267 |
|
2018
Q4 | $3.6M | Sell |
856,749
-295,218
| -26% | -$1.24M | ﹤0.01% | 2134 |
|
2018
Q3 | $7.22M | Buy |
1,151,967
+580,966
| +102% | +$3.64M | ﹤0.01% | 1930 |
|
2018
Q2 | $4.59M | Buy |
571,001
+276,282
| +94% | +$2.22M | ﹤0.01% | 2188 |
|
2018
Q1 | $2.2M | Buy |
294,719
+105,101
| +55% | +$784K | ﹤0.01% | 2518 |
|
2017
Q4 | $1.13M | Buy |
189,618
+18,027
| +11% | +$107K | ﹤0.01% | 2948 |
|
2017
Q3 | $1.26M | Sell |
171,591
-526,274
| -75% | -$3.87M | ﹤0.01% | 2876 |
|
2017
Q2 | $4.74M | Sell |
697,865
-726,149
| -51% | -$4.93M | ﹤0.01% | 1996 |
|
2017
Q1 | $13.4M | Buy |
1,424,014
+1,028,388
| +260% | +$9.71M | ﹤0.01% | 1379 |
|
2016
Q4 | $3.42M | Buy |
+395,626
| New | +$3.42M | ﹤0.01% | 2222 |
|
2016
Q3 | – | Sell |
-100,059
| Closed | -$422K | – | 3668 |
|
2016
Q2 | $422K | Sell |
100,059
-196,837
| -66% | -$830K | ﹤0.01% | 3308 |
|
2016
Q1 | $1.29M | Sell |
296,896
-40,200
| -12% | -$175K | ﹤0.01% | 2753 |
|
2015
Q4 | $2.07M | Buy |
337,096
+3,831
| +1% | +$23.5K | ﹤0.01% | 2505 |
|
2015
Q3 | $1.91M | Buy |
333,265
+332,555
| +46,839% | +$1.9M | ﹤0.01% | 2538 |
|
2015
Q2 | $5K | Buy |
+710
| New | +$5K | ﹤0.01% | 4247 |
|
2014
Q2 | – | Sell |
-29,948
| Closed | -$122K | – | 4103 |
|
2014
Q1 | $122K | Buy |
+29,948
| New | +$122K | ﹤0.01% | 3902 |
|